How much Hawkeye from 'M*A*S*H' likely retired with, from pay and benefits to what his military service meant for his ...

The trial aims to enrol approximately 50 MASH patients.

Inipharm, a clinical-stage biopharmaceutical company focused on developing therapies for fibrotic liver diseases, today ...

Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Meena Bansal, MD, discusses the evolving MASH pipeline and why precision phenotyping, biomarkers, and cardiovascular outcomes ...